Keiichi Fukuda, M.D., Ph.D., President and CEO of Heartseed Inc., will be speaking at the 10th Cardiovascular Bioengineering (CVBE) Symposium 2026, to be held in Göttingen, Germany, from June 18 to 20, 2026.

The CVBE Symposium is an international conference that brings together global leaders in fundamental and translational research related to heart regeneration and repair.

Dr. Fukuda will speak in "Session V: Heart Repair in Clinical Trials" on June 19 (local time). Under the title "Clinical trial of iPS cell-derived cardiomyocyte spheroid transplantation to severe heart failure patients due to ischemic heart disease", his presentation will focus on the LAPiS study, a clinical trial conducted by Heartseed."

Presentation Details:

• Date & Time: June 19, 2026 (Fri), 15:40-16:00 (Local Time)
• Venue: German Primate Center, Kellnerweg 4, 37077 Göttingen, Germany
• Session: Session V: Heart Repair in Clinical Trials
• Presentation Title: "Clinical trial of iPS cell-derived cardiomyocyte spheroid transplantation to severe heart failure patients due to ischemic heart disease"

For more information and the full program, please visit the official website:
https://dzhk.de/newsroom/events/cvbe-2026